Autobio Diagnostics Co., Ltd. (603658.SS)
CNY 41.78
(-0.38%)
CNY 41.78
(-0.38%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.46 Billion | 1.55 Billion | 1.46 Billion | 994.71 Million | 842.88 Million | 653.72 Million |
| Net Income | 1.21 Billion | 1.18 Billion | 979.85 Million | 757.09 Million | 786.89 Million | 575 Million |
| Depreciation & Amortization | 481.47 Million | 432.52 Million | 397.11 Million | 301.55 Million | 217.69 Million | 165 Million |
| Deferred income taxes | -50.88 Million | -33.03 Million | -10.51 Million | 53.9 Million | 44.16 Million | -12.81 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -136.37 Million | -51.48 Million | 142.61 Million | -132.92 Million | -205.4 Million | -85.61 Million |
| Other non-cash items | 1.05 Billion | -11.3 Million | -58.34 Million | 68.99 Million | 43.69 Million | -671.57 Thousand |
| Investing Cash Flow | -787.22 Million | -978.66 Million | -510.8 Million | -3.48 Billion | -1.23 Billion | -345.56 Million |
| Investments in PPE | -900.41 Million | -938.32 Million | -1.06 Billion | -1.11 Billion | -762.07 Million | -410.17 Million |
| Acquisitions | -68.51 Thousand | 2.4 Million | 280.2 Thousand | 26.01 Million | -4.87 Million | 33.5 Thousand |
| Investment purchases | -3.4 Billion | -10.06 Million | -1.93 Million | -6.97 Billion | -77.24 Million | -1.84 Billion |
| Sales/Maturities of investments | 3.53 Billion | 7.45 Million | 345.06 Million | 41.75 Million | 777 Thousand | 1.92 Billion |
| Other Investing Activities | -18.75 Million | -40.13 Million | 211.62 Million | 4.53 Billion | -391.25 Million | 64.6 Million |
| Financing Cash Flow | -337.01 Million | -218.26 Million | -502.34 Million | 2.68 Billion | 470.96 Million | -276.56 Million |
| Debt repayment | -537.24 Million | -200 Million | -332.7 Million | -313.24 Million | -316.89 Million | -5.08 Million |
| Dividends payments | -464.8 Million | -418.93 Million | -383.33 Million | -387.54 Million | -336 Million | -305.93 Million |
| Common Stock Repurchased | - | -243.3 Million | -16.79 Million | -56.37 Million | - | - |
| Common Stock Issuance | - | 243.3 Million | 16.79 Million | 56.37 Million | - | - |
| Other Financing Activities | -395.13 Million | 420.64 Million | 225.16 Million | 3.38 Billion | 1.13 Billion | 34.45 Million |
| Accounts receivables | -117.25 Million | -44.06 Million | -57.75 Million | -410.86 Million | -394.47 Million | -181.31 Million |
| Accounts payables | 18.51 Million | 218.89 Million | 324.36 Million | 357.32 Million | 228.24 Million | 171.35 Million |
| Inventory | -37.79 Million | -193.27 Million | -113.47 Million | -133.3 Million | -83.34 Million | -62.83 Million |
| Other working capital | 168.52 Thousand | -33.03 Million | -10.51 Million | 53.9 Million | 44.16 Million | -22.78 Million |
| Cash at beginning of period | 1.13 Billion | 767.39 Million | 327.54 Million | 136.88 Million | 57.6 Million | 26.93 Million |
| Cash at end of period | 1.48 Billion | 1.13 Billion | 767.39 Million | 327.54 Million | 136.88 Million | 57.6 Million |
| Capital Expenditure | -900.41 Million | -938.32 Million | -1.06 Billion | -1.11 Billion | -762.07 Million | -410.17 Million |
| Effect of forex changes on cash | 3.14 Million | 7.71 Million | -8.23 Million | -675.32 Thousand | 90.05 Thousand | -923.91 Thousand |
| Net cash flow / Change in cash | 348.86 Million | 369.2 Million | 439.84 Million | 190.66 Million | 79.27 Million | 30.67 Million |
| Free Cash Flow | 569.43 Million | 620.09 Million | 395.39 Million | -120.66 Million | 80.81 Million | 243.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 336.66 Million | 295.3 Million | 324.21 Million | 316.51 Million | 1.21 Billion | 355.04 Million |
| Depreciation & Amortization | - | 124.75 Million | 124.75 Million | 121.47 Million | 481.47 Million | -222.29 Million |
| Deferred income taxes | - | -48.48 Million | - | - | -50.88 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -122.52 Million | - | -154.88 Million | -136.37 Million | 2.68 Million |
| Other non-cash items | 116.81 Million | 45.02 Million | 4.19 Million | 235.63 Million | 1.05 Billion | 279.23 Million |
| Investing Cash Flow | -381.3 Million | 31.22 Million | -622.98 Million | 670.22 Million | -787.22 Million | -513.5 Million |
| Investments in PPE | -158.19 Million | -151.7 Million | -231.03 Million | -216.63 Million | -900.41 Million | -254.67 Million |
| Acquisitions | 71.49 Thousand | -1.75 Million | 110.44 Thousand | -345.51 Thousand | -68.51 Thousand | 584.87 Thousand |
| Investment purchases | -18 Million | -941.2 Million | -7.5 Million | -3.3 Billion | -3.4 Billion | -62.88 Million |
| Sales/Maturities of investments | -741.33 Million | 741.33 Million | 1.00 | 3.53 Billion | 3.53 Billion | -104.1 Million |
| Other Investing Activities | -205.11 Million | 624.89 Million | -384.56 Million | 652.3 Million | -18.75 Million | -92.42 Million |
| Financing Cash Flow | -101.91 Million | -926.95 Million | -113.18 Million | -145.3 Million | -337.01 Million | 70.25 Million |
| Debt repayment | -3 Million | -184 Million | -36 Million | -12.25 Million | -537.24 Million | -100.33 Million |
| Dividends payments | -3.91 Million | -612.05 Million | -4.29 Million | -464.8 Million | -464.8 Million | -425.56 Thousand |
| Common Stock Repurchased | - | -321.03 Million | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -101 Million | -737.66 Million | -149.18 Million | 346.06 Million | -395.13 Million | 171.01 Million |
| Accounts receivables | - | -77.26 Million | - | -117.25 Million | -117.25 Million | 29.05 Million |
| Accounts payables | - | - | - | - | 18.51 Million | -1.61 Million |
| Inventory | - | -106.55 Million | - | -37.79 Million | -37.79 Million | -26.36 Million |
| Other working capital | - | 61.29 Million | - | 168.52 Thousand | 168.52 Thousand | 1.61 Million |
| Cash at beginning of period | 349.1 Million | 1.07 Billion | 1.48 Billion | 443.06 Million | 1.13 Billion | 470.6 Million |
| Cash at end of period | 319.75 Million | 350.14 Million | 1.07 Billion | 1.48 Billion | 1.48 Billion | 442.04 Million |
| Capital Expenditure | -158.19 Million | -151.7 Million | -231.03 Million | -216.63 Million | -900.41 Million | -254.67 Million |
| Effect of forex changes on cash | 398.53 Thousand | 313.74 Thousand | -170.32 Thousand | -332.54 Thousand | 3.14 Million | 21.38 Thousand |
| Net cash flow / Change in cash | -29.34 Million | -728.4 Million | -407.93 Million | 1.04 Billion | 348.86 Million | -28.55 Million |
| Free Cash Flow | 295.27 Million | 15.38 Million | 97.36 Million | 302.1 Million | 569.43 Million | 159.99 Million |
MSTO
EVK
SYF-PA
BBRRF
SLNCF
1038